Individualized Pharmaceutical-care in Outpatients With Cancer Pain

U

University of Chinese Academy Sciences

Status

Unknown

Conditions

Cancer Pain

Treatments

Other: Pharmaceutical care

Study type

Interventional

Funder types

Other

Identifiers

NCT03439904
ECCOPG-003

Details and patient eligibility

About

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients

Full description

This study is a prospective multicenter randomized controlled study to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients treated with sustained released morphine, oxycodone, and transdermal fentanyl.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

* Patients aged 18 years or older; * Histologically confirmed solid tumor; * Diagnosed chronic cancer pain; * Opioid-tolerant patients; * Overall survival is expected to be over 3 months; * Karnofsky performance score≥50; * Willing and able to comply with the protocol

Exclusion criteria

* Patients aged 18 years or older; * Histologically confirmed solid tumor; * Diagnosed chronic cancer pain; * Opioid-tolerant patients; * Overall survival is expected to be over 3 months; * Karnofsky performance score≥50; * Willing and able to comply with the protocol

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

pharmaceutical care intervention group
Experimental group
Description:
Patients will receive individualized pharmaceutical care in addition to usual medical care
Treatment:
Other: Pharmaceutical care
control group
No Intervention group
Description:
Patients will receive usual medical care

Trial contacts and locations

1

Loading...

Central trial contact

Ping Huang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems